R 1530
Tocris Bioscience, part of Bio-Techne | Catalog # 4885
Multi-RTK inhibitor; inhibits angiogenesis
Discontinued Product
4885 has been discontinued.
View all Additional RTK Inhibitors products.
Key Product Details
Description
Multi-RTK inhibitor; inhibits angiogenesis
Product Description
R 1530 is a multi-kinase inhibitor. Exhibits inhibitory activity against Chk2, KDR, FGFR, Aurora A kinase and Cdk2 (IC50 values are 24, 34, 50, 58 and 88 nM respectively). Also binds VEGFR-2, FGFR1 and PDGFRβ (Kd values are 0.015, 0.061 and 0.088 μM respectively). Displays antiproliferative activity in vitro; inhibits mitosis and angiogenesis. Orally bioavailable.Product Specifications
Molecular Weight
356.78
Formula
C18H14ClFN4O
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo[3,4-b][1,4]benzodiazepine
CAS Number
882531-87-5
PubChem ID
11610113
InChI Key
UOVCGJXDGOGOCZ-UHFFFAOYSA-N
SMILES
FC(C(OC)=C1)=CC2=C1NC3=NNC(C)=C3N=C2C4=C(Cl)C=CC=C4
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 35.68 | 100 | |
| Ethanol | 35.68 | 100 |
Preparing Stock Solutions
for R 1530
The following data is based on the product molecular weight 356.78
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.80 mL | 14.01 mL | 28.03 mL |
| 5 mM | 0.56 mL | 2.80 mL | 5.61 mL |
| 10 mM | 0.28 mL | 1.40 mL | 2.80 mL |
| 50 mM | 0.06 mL | 0.28 mL | 0.56 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Tovar Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: implications for therapy. Cell Cycle 2010 PMID: 20814247
- Liu Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor R1530 for the treatment of solid tumors. ACS Med.Chem.Lett.
Product Specific Notices for R 1530
For research use only
Loading...
Loading...